Bill Gates commits $30m towards Alzheimer’s diagnostic test
July 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis
Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …
Janssen’s Symtuza scores approval with the FDA in HIV-1
July 18, 2018Sales and Marketing HIV, Janssen, Symtuza, pharma
Janssen has announced that Symtuza (D/C/F/TAF) has received approval from the FDA in the treatment of human immunodeficiency virus type …
AstraZeneca increases drug stockpile in preparation for no-deal Brexit
July 18, 2018Research and Development AstraZeneca, brexit, no-deal, pharma, stockpiling
The Anglo-Swedish drug giant AstraZeneca is set to increase its stockpile of drugs in both the United Kingdom and the …
Novartis follows Pfizer’s lead, pledges no price hikes in 2018
July 18, 2018Research and Development, Sales and Marketing Novartis, Pfizer, President trump, Trump, US, pharma
Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the …
Researchers develop algorithm able to identify antidepressant suitability
July 18, 2018Research and Development McLean, algorithm, antidepressants, research
A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm …
AbbVie and Mylan reach US marketing agreement for Humira biosimilar
July 18, 2018Research and Development, Sales and Marketing AbbVie, Humira, Mylan, US, pharma
AbbVie and Mylan have announced that they have both signed a licensing agreement for the former’s proposed biosimilar version of …
Renowned cancer researcher leaves ICR over bullying allegations
July 17, 2018Research and Development
Leading geneticist and cancer researcher, Nazneen Rahman CBE, has resigned from her position as head of Genetics and Epidemiology at …
Silence Therapeutics appoints ex-Akari CEO in top position
July 17, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand
Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …
Researchers successfully minimise diabetes drug side-effects in animal models
July 17, 2018Manufacturing and Production, Research and Development FDA, diabetes, pharma, type 2 diabetes
Researchers at the University of Pennsylvania and Syracuse University have modified a key ingredient of current diabetes drugs to produce …
Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?
July 17, 2018Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma
Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …
J&J stops Invokana trial early after success in kidney disease and type 2 diabetes
July 17, 2018Manufacturing and Production, Research and Development J&J, JJ, Janssen, Johnson & Johnson, invokana, kidney disease, pharma, renal, type 2 diabetesm diabetes
Johnson & Johnson and research arm Janssen have taken the decision to terminate a Phase 3 trial evaluating the efficacy …
FDA cautions consumers on fake warning letter scam
July 17, 2018Manufacturing and Production FDA, fake, letter, scam, warning
The FDA has warned that criminals have been targeting customers who bought medicines online or over the phone with “official-looking, …
CRISPR gene editing may frequently cause undetected genetic damage
July 17, 2018Manufacturing and Production DNA, crispr, gene editing, genetic damage
Scientists studying the gene editing technology CRISPR-Cas9 have discovered the technique appears to frequently cause genetic damage that may slip …
Senate claims Novartis misled public on Trump lawyer deal
July 16, 2018Sales and Marketing Novartis, Senate, Trump, United States, deal
A report released by the United States Senate has found that Novartis’ relationship with Donald Trump’s long-time lawyer Michael Cohen …
Recruitment and retention: How can we do better?
July 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, patient recruitment, patients, pharma
In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt …
FDA expands Pfizer and Astellas’ Xtandi into castration-resistant prostate cancer
July 16, 2018Sales and Marketing Astellas, Cancer, FDA, Pfizer, US, Xtandi, pharma, prostate cancer
Astellas and Pfizer have revealed that their androgen receptor inhibitor Xtandi (enzalutamide) has received approval from the FDA to expand …
FDA approves first smallpox therapy to defend against bioterrorism
July 16, 2018Sales and Marketing FDA, pharma, smallpox
The FDA has announced that it has awarded marketing authorisation to SIGA Technologies’ TPOXX (tecovirimat) in the first approval of …
European cannabis market set to be worth €115.7 billion by 2028
July 16, 2018Sales and Marketing Europe, Legislation, cannabis, medicinal marijuana
The European cannabis market is set to be worth €115.7 billion by 2028, according to a report released by the …
Indivior shares soar as US judge rules against Dr Reddy
July 16, 2018Sales and Marketing
Shares in the London listed addiction specialist Indivior surged in price today, as the Indian pharmaceutical company Dr Reddy’s Laboratories …
GSK confirms £250m deal to sell experimental drug to Dermavent Sciences
July 13, 2018Medical Communications Dermavent, GSK, Roivant, tapinarof
British company GlaxoSmithKline has announced that it will sell the rights to its experimental dermatology drug, tapinarof, to Roivant Sciences’ …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
